{"disease":{"id":"tinea","name":"tinea"},"drugs":{"marketed":[{"drug_id":"econazole-nitrate","indication_name":"Interdigital tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"ECONAZOLE NITRATE","company_name":"","drug_phase":"marketed","molecular_target":"","drug_class":"","quality_score":30,"revenue":null,"mechanism":null},{"drug_id":"naftifine","indication_name":"Interdigital tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naftin","generic_name":"NAFTIFINE","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Allylamine Antifungal","quality_score":55,"revenue":null,"mechanism":"Naftin works by inhibiting the synthesis of ergosterol in fungal cell membranes."},{"drug_id":"clotrimazole","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotrimin","generic_name":"clotrimazole","company_name":"Bayer AG","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clotrimazole","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotrimin","generic_name":"clotrimazole","company_name":"Bayer AG","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clotrimazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Lotrimin","generic_name":"clotrimazole","company_name":"Bayer AG","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"cortisone-acetate","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortone","generic_name":"CORTISONE ACETATE","company_name":"","drug_phase":"marketed","molecular_target":"Corticosteroid-binding globulin","drug_class":"alpha-Adrenergic Agonist [EPC]","quality_score":29,"revenue":null,"mechanism":""},{"drug_id":"betamethasone-dipropionate","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diprolene","generic_name":"BETAMETHASONE DIPROPIONATE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":51,"revenue":null,"mechanism":"Diprolene works by binding to the glucocorticoid receptor in the skin, which reduces inflammation and suppresses the immune system."},{"drug_id":"betamethasone-dipropionate","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diprolene","generic_name":"BETAMETHASONE DIPROPIONATE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":51,"revenue":null,"mechanism":"Diprolene works by binding to the glucocorticoid receptor in the skin, which reduces inflammation and suppresses the immune system."},{"drug_id":"betamethasone-dipropionate","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Diprolene","generic_name":"BETAMETHASONE DIPROPIONATE","company_name":"Merck & Co.","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":51,"revenue":null,"mechanism":"Diprolene works by binding to the glucocorticoid receptor in the skin, which reduces inflammation and suppresses the immune system."},{"drug_id":"sulconazole","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exelderm","generic_name":"SULCONAZOLE","company_name":"Journey","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19","drug_class":"Azole Antifungal","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"sulconazole","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exelderm","generic_name":"SULCONAZOLE","company_name":"Journey","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19","drug_class":"Azole Antifungal","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"sulconazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Exelderm","generic_name":"SULCONAZOLE","company_name":"Journey","drug_phase":"marketed","molecular_target":"Cytochrome P450 2C19","drug_class":"Azole Antifungal","quality_score":36,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin","indication_name":"Tinea barbae","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Grifulvin V","generic_name":"GRISEOFULVIN","company_name":"Johnson And Johnson","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin","indication_name":"Tinea capitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Grifulvin V","generic_name":"GRISEOFULVIN","company_name":"Johnson And Johnson","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Grifulvin V","generic_name":"GRISEOFULVIN","company_name":"Johnson And Johnson","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Grifulvin V","generic_name":"GRISEOFULVIN","company_name":"Johnson And Johnson","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Grifulvin V","generic_name":"GRISEOFULVIN","company_name":"Johnson And Johnson","drug_phase":"marketed","molecular_target":"Solute carrier family 22 member 1","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":51,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrosize","indication_name":"Tinea barbae","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FULVICIN P/G 330","generic_name":"GRISEOFULVIN, ULTRAMICROSIZE","company_name":"CHARTWELL RX","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrosize","indication_name":"Tinea capitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FULVICIN P/G 330","generic_name":"GRISEOFULVIN, ULTRAMICROSIZE","company_name":"CHARTWELL RX","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrosize","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FULVICIN P/G 330","generic_name":"GRISEOFULVIN, ULTRAMICROSIZE","company_name":"CHARTWELL RX","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrosize","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FULVICIN P/G 330","generic_name":"GRISEOFULVIN, ULTRAMICROSIZE","company_name":"CHARTWELL RX","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrosize","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"FULVICIN P/G 330","generic_name":"GRISEOFULVIN, ULTRAMICROSIZE","company_name":"CHARTWELL RX","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"butenafine","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mentax","generic_name":"BUTENAFINE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Benzylamine Antifungal","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"butenafine","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mentax","generic_name":"BUTENAFINE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Benzylamine Antifungal","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"butenafine","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Mentax","generic_name":"BUTENAFINE","company_name":"Bayer","drug_phase":"marketed","molecular_target":"Cytochrome P450 2D6","drug_class":"Benzylamine Antifungal","quality_score":24,"revenue":null,"mechanism":""},{"drug_id":"naftifine","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naftin","generic_name":"NAFTIFINE","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Allylamine Antifungal","quality_score":55,"revenue":null,"mechanism":"Naftin works by inhibiting the synthesis of ergosterol in fungal cell membranes."},{"drug_id":"griseofulvin-microsize","indication_name":"Tinea barbae","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISEOFULVIN","generic_name":"GRISEOFULVIN, MICROSIZE","company_name":"COSETTE","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microsize","indication_name":"Tinea capitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISEOFULVIN","generic_name":"GRISEOFULVIN, MICROSIZE","company_name":"COSETTE","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microsize","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISEOFULVIN","generic_name":"GRISEOFULVIN, MICROSIZE","company_name":"COSETTE","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microsize","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISEOFULVIN","generic_name":"GRISEOFULVIN, MICROSIZE","company_name":"COSETTE","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microsize","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISEOFULVIN","generic_name":"GRISEOFULVIN, MICROSIZE","company_name":"COSETTE","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"Tubulin Inhibiting Agent [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrocrystalline","indication_name":"Tinea barbae","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISACTIN ULTRA","generic_name":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","company_name":"WYETH AYERST","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrocrystalline","indication_name":"Tinea capitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISACTIN ULTRA","generic_name":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","company_name":"WYETH AYERST","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrocrystalline","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISACTIN ULTRA","generic_name":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","company_name":"WYETH AYERST","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrocrystalline","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISACTIN ULTRA","generic_name":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","company_name":"WYETH AYERST","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-ultramicrocrystalline","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRISACTIN ULTRA","generic_name":"GRISEOFULVIN, ULTRAMICROCRYSTALLINE","company_name":"WYETH AYERST","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"naftifine","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naftin","generic_name":"NAFTIFINE","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Allylamine Antifungal","quality_score":55,"revenue":null,"mechanism":"Naftin works by inhibiting the synthesis of ergosterol in fungal cell membranes."},{"drug_id":"hydrocortisone","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"hydrocortisone","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cortef","generic_name":"hydrocortisone","company_name":"Generic (originally Merck/Upjohn)","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"Corticosteroid [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clioquinol","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cliquinol","generic_name":"CLIOQUINOL","company_name":"","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clioquinol","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cliquinol","generic_name":"CLIOQUINOL","company_name":"","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"clioquinol","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Cliquinol","generic_name":"CLIOQUINOL","company_name":"","drug_phase":"marketed","molecular_target":"Amyloid beta A4 protein","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"econazole","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spectazole","generic_name":"ECONAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"Thromboxane-A synthase","drug_class":"Azole Antifungal","quality_score":48,"revenue":null,"mechanism":"Spectazole works by inhibiting the enzyme lanosterol 14α-demethylase, which is necessary for fungal cells to produce ergosterol, a critical component of their cell membranes."},{"drug_id":"econazole","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spectazole","generic_name":"ECONAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"Thromboxane-A synthase","drug_class":"Azole Antifungal","quality_score":48,"revenue":null,"mechanism":"Spectazole works by inhibiting the enzyme lanosterol 14α-demethylase, which is necessary for fungal cells to produce ergosterol, a critical component of their cell membranes."},{"drug_id":"econazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Spectazole","generic_name":"ECONAZOLE","company_name":"","drug_phase":"marketed","molecular_target":"Thromboxane-A synthase","drug_class":"Azole Antifungal","quality_score":48,"revenue":null,"mechanism":"Spectazole works by inhibiting the enzyme lanosterol 14α-demethylase, which is necessary for fungal cells to produce ergosterol, a critical component of their cell membranes."},{"drug_id":"miconazole","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monistat","generic_name":"miconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Imidazole antifungal","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"miconazole","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monistat","generic_name":"miconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Imidazole antifungal","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"miconazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Monistat","generic_name":"miconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"7-alpha-hydroxycholest-4-en-3-one 12-alpha-hydroxylase, Malate dehydrogenase cytoplasmic , 5-hydroxytryptamine receptor 6","drug_class":"Imidazole antifungal","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"naftifine","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Naftin","generic_name":"NAFTIFINE","company_name":"Legacy Pharma","drug_phase":"marketed","molecular_target":"Sigma non-opioid intracellular receptor 1","drug_class":"Allylamine Antifungal","quality_score":55,"revenue":null,"mechanism":"Naftin works by inhibiting the synthesis of ergosterol in fungal cell membranes."},{"drug_id":"ketoconazole","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nizoral","generic_name":"ketoconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Cytochrome P450 21, Sodium/nucleoside cotransporter 1","drug_class":"Azole Antifungal [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ketoconazole","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nizoral","generic_name":"ketoconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Cytochrome P450 21, Sodium/nucleoside cotransporter 1","drug_class":"Azole Antifungal [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"ketoconazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Nizoral","generic_name":"ketoconazole","company_name":"Johnson & Johnson (Janssen)","drug_phase":"marketed","molecular_target":"Aldehyde oxidase, Cytochrome P450 21, Sodium/nucleoside cotransporter 1","drug_class":"Azole Antifungal [EPC]","quality_score":40,"revenue":null,"mechanism":""},{"drug_id":"haloprogin","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"HALOPROGIN","company_name":"Westwood Squibb","drug_phase":"marketed","molecular_target":"Adenosine receptor A3","drug_class":"haloprogin","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"haloprogin","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"HALOPROGIN","company_name":"Westwood Squibb","drug_phase":"marketed","molecular_target":"Adenosine receptor A3","drug_class":"haloprogin","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"haloprogin","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"HALOPROGIN","company_name":"Westwood Squibb","drug_phase":"marketed","molecular_target":"Adenosine receptor A3","drug_class":"haloprogin","quality_score":10,"revenue":null,"mechanism":""},{"drug_id":"benzocaine","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norcaine","generic_name":"BENZOCAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"benzocaine","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norcaine","generic_name":"BENZOCAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"benzocaine","indication_name":"Tinea Infections","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Norcaine","generic_name":"BENZOCAINE","company_name":"","drug_phase":"marketed","molecular_target":"Sodium channel protein type 5 subunit alpha","drug_class":"Standardized Chemical Allergen [EPC]","quality_score":23,"revenue":null,"mechanism":""},{"drug_id":"luliconazole","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Luzu","generic_name":"LULICONAZOLE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":"Luzu works by inhibiting the growth of fungi by targeting a specific enzyme."},{"drug_id":"luliconazole","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Luzu","generic_name":"LULICONAZOLE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":"Luzu works by inhibiting the growth of fungi by targeting a specific enzyme."},{"drug_id":"luliconazole","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Luzu","generic_name":"LULICONAZOLE","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"","drug_class":"Azole Antifungal [EPC]","quality_score":10,"revenue":null,"mechanism":"Luzu works by inhibiting the growth of fungi by targeting a specific enzyme."},{"drug_id":"betamethasone","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"betamethasone","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"betamethasone","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Betametasone","generic_name":"BETAMETHASONE","company_name":"","drug_phase":"marketed","molecular_target":"Glucocorticoid receptor","drug_class":"Corticosteroid","quality_score":65,"revenue":null,"mechanism":"Betamethasone works by binding to the glucocorticoid receptor, which then triggers a series of downstream effects that reduce inflammation and suppress the immune system."},{"drug_id":"ciclopirox","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loprox","generic_name":"CICLOPIROX","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Poly [ADP-ribose] polymerase 1","drug_class":"ciclopirox","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"ciclopirox","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loprox","generic_name":"CICLOPIROX","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Poly [ADP-ribose] polymerase 1","drug_class":"ciclopirox","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"ciclopirox","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"Loprox","generic_name":"CICLOPIROX","company_name":"Bausch Health","drug_phase":"marketed","molecular_target":"Poly [ADP-ribose] polymerase 1","drug_class":"ciclopirox","quality_score":55,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microcrystalline","indication_name":"Tinea barbae","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRIFULVIN V","generic_name":"GRISEOFULVIN, MICROCRYSTALLINE","company_name":"JOHNSON AND JOHNSON","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microcrystalline","indication_name":"Tinea capitis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRIFULVIN V","generic_name":"GRISEOFULVIN, MICROCRYSTALLINE","company_name":"JOHNSON AND JOHNSON","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microcrystalline","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRIFULVIN V","generic_name":"GRISEOFULVIN, MICROCRYSTALLINE","company_name":"JOHNSON AND JOHNSON","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microcrystalline","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRIFULVIN V","generic_name":"GRISEOFULVIN, MICROCRYSTALLINE","company_name":"JOHNSON AND JOHNSON","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"griseofulvin-microcrystalline","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":"GRIFULVIN V","generic_name":"GRISEOFULVIN, MICROCRYSTALLINE","company_name":"JOHNSON AND JOHNSON","drug_phase":"marketed","molecular_target":"Lanosterol 14-alpha demethylase, Solute carrier family 22 member 1, Tubulin","drug_class":"","quality_score":null,"revenue":null,"mechanism":""},{"drug_id":"cortisol","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cortisol","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"cortisol","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Cortisol","company_name":"University of Zurich","drug_phase":"marketed","molecular_target":"Annexin A1, Corticosteroid-binding globulin, Nitric oxide synthase, inducible","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pramocaine","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pramocaine","company_name":"","drug_phase":"unknown","molecular_target":"Sigma non-opioid intracellular receptor 1, Sodium channel alpha subunits; brain (Types I, II, III), Membrane-associated progesterone receptor component 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pramocaine","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pramocaine","company_name":"","drug_phase":"unknown","molecular_target":"Sigma non-opioid intracellular receptor 1, Sodium channel alpha subunits; brain (Types I, II, III), Membrane-associated progesterone receptor component 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"pramocaine","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"pramocaine","company_name":"","drug_phase":"unknown","molecular_target":"Sigma non-opioid intracellular receptor 1, Sodium channel alpha subunits; brain (Types I, II, III), Membrane-associated progesterone receptor component 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"penlac","indication_name":"Tinea corporis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Penlac","company_name":"9305-9954 Quebec Inc","drug_phase":"phase_2","molecular_target":"Deoxyhypusine hydroxylase, Poly [ADP-ribose] polymerase 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"penlac","indication_name":"Tinea cruris","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Penlac","company_name":"9305-9954 Quebec Inc","drug_phase":"phase_2","molecular_target":"Deoxyhypusine hydroxylase, Poly [ADP-ribose] polymerase 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null},{"drug_id":"penlac","indication_name":"Tinea pedis","indication_type":"approved","phase":null,"line_of_therapy":null,"is_primary_indication":false,"pivotal_trial_result":null,"pivotal_trial_p_value":null,"patient_population":null,"brand_name":null,"generic_name":"Penlac","company_name":"9305-9954 Quebec Inc","drug_phase":"phase_2","molecular_target":"Deoxyhypusine hydroxylase, Poly [ADP-ribose] polymerase 1","drug_class":"","quality_score":null,"revenue":null,"mechanism":null}],"pipeline":[],"offLabel":[],"totalMarketed":84,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT02335255","title":"Evaluate Safety and Efficacy of Naftifine Hydrochloride Gel 2% and Naftin® Gel 2% in Tinea Pedis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":1519,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT03129321","title":"Therapeutic Equivalence and Safety of Two Econazole Nitrate Cream, 1% Products in Tinea Pedis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":876,"lead_sponsor_name":"Mylan Inc.","has_results":true},{"nct_id":"NCT03824912","title":"Clinical Study to Evaluate the Therapeutic Equivalence of Ketoconazole Cream 2% in the Treatment of Tinea Pedis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":831,"lead_sponsor_name":"Encube Ethicals Pvt. Ltd.","has_results":true},{"nct_id":"NCT04203342","title":"A Therapeutic Equivalence Study of Ketoconazole Cream 2%","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":682,"lead_sponsor_name":"Douglas Pharmaceuticals America Ltd","has_results":false},{"nct_id":"NCT06305637","title":"A Study Comparing Ketoconazole Shampoo, 2% and Ketoconazole 2% Shampoo (RS) in the Treatment of Tinea Versicolor.","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":430,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT07441005","title":"Comparative Efficacy of Topical Oxiconazole Cream (1%) Versus Topical Clotrimazole Cream (1%) in the Treatment of Tinea CrurisAbstract","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":386,"lead_sponsor_name":"Hayat Abad Medical Complex, Peshawar","has_results":false},{"nct_id":"NCT03320486","title":"Non-inferiority Trial of Dapaconazole Versus Ketoconazole","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":360,"lead_sponsor_name":"Biolab Sanus Farmaceutica","has_results":false},{"nct_id":"NCT03897257","title":"A Comparison Study of UHE-103 Cream in Subjects With Moccasin Type Tinea Pedis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":240,"lead_sponsor_name":"Therapeutics, Inc.","has_results":false},{"nct_id":"NCT07056660","title":"Atmospheric Pressure Cold Plasma for Moderate-to-severe Tinea Pedis","phase":"NA","overall_status":"RECRUITING","enrollment_count":220,"lead_sponsor_name":"Shenyang Medical College","has_results":false},{"nct_id":"NCT04144491","title":"Effect of L. Rhamnosus Yoba on RTI and Other Health Outcomes Among Children (3-6 Years) in Uganda","phase":"NA","overall_status":"COMPLETED","enrollment_count":195,"lead_sponsor_name":"VU University of Amsterdam","has_results":false},{"nct_id":"NCT07068256","title":"Efficacy Comparison of Itraconazole Pulse Therapy and Terbinafine Therapy in Treatment of Tinea Capitis in Children.","phase":"NA","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Muhammad Aamir Latif","has_results":false},{"nct_id":"NCT05862714","title":"Comparison of Efficacy of Single Oral Dose Fluconazole and Itraconazole in Patients With Pityriasis Versicolor","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":164,"lead_sponsor_name":"Combined Military Hospital Abbottabad","has_results":false},{"nct_id":"NCT04883593","title":"A Study Comparing the Efficacy of TA103 and the Placebo Control in the Treatment of Interdigital Tinea Pedis.","phase":"EARLY_PHASE1","overall_status":"COMPLETED","enrollment_count":160,"lead_sponsor_name":"Sun Pharmaceutical Industries, Inc.","has_results":false},{"nct_id":"NCT07043582","title":"Trichoscopic Predictors of Treatment Response in Tinea Capitis: A Prospective Study","phase":"","overall_status":"NOT_YET_RECRUITING","enrollment_count":150,"lead_sponsor_name":"Istanbul Medeniyet University","has_results":false},{"nct_id":"NCT07342153","title":"Comparing the Efficacy of Oral Fluconazole Versus Oral Itraconazole in Treating Resistant Tinea Corporis","phase":"PHASE4","overall_status":"RECRUITING","enrollment_count":126,"lead_sponsor_name":"Urooj Fatima","has_results":false},{"nct_id":"NCT02582177","title":"Effectiveness Study of Ketoconazole and Betamethasone to Treat Fungal Infection and Dermatophytosis","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":125,"lead_sponsor_name":"Ache Laboratorios Farmaceuticos S.A.","has_results":false},{"nct_id":"NCT07184203","title":"Comparison Between Continuous and Pulse Itraconazole in Tinea Capitis in Children","phase":"NA","overall_status":"RECRUITING","enrollment_count":120,"lead_sponsor_name":"Alexandria University","has_results":false},{"nct_id":"NCT02550496","title":"Evaluation of Trichoscopy in the Diagnosis of Tinea Capitis","phase":"NA","overall_status":"COMPLETED","enrollment_count":104,"lead_sponsor_name":"Centre Hospitalier Universitaire, Amiens","has_results":false},{"nct_id":"NCT06869681","title":"Efficacy of Tropical Sertaconazole Nitrate 2% Vs Clotrimazole 1% for Tinea Pedis","phase":"PHASE4","overall_status":"NOT_YET_RECRUITING","enrollment_count":100,"lead_sponsor_name":"Jinnah Postgraduate Medical Centre","has_results":false},{"nct_id":"NCT03135912","title":"Three-Arm Trial of Novel Treatment for Tinea Pedis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":90,"lead_sponsor_name":"South End Skin Care","has_results":false},{"nct_id":"NCT02767947","title":"Safety and Efficacy of Product 33525 (Luliconazole Cream 1%) in Pediatric Participants With Tinea Corporis","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":75,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT07046988","title":"Population Pharmacokinetics of Terbinafine in Children With Tinea Capitis","phase":"","overall_status":"RECRUITING","enrollment_count":60,"lead_sponsor_name":"Shandong University","has_results":false},{"nct_id":"NCT03405818","title":"An Evaluation of the Safety and Pharmacokinetics of Tavaborole Topical Solution for the Treatment of Fungal Disease of the Toenail in Children and Adolescents","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":55,"lead_sponsor_name":"Pfizer","has_results":true},{"nct_id":"NCT03359070","title":"Clinical Trial Comparing Dapaconazole Versus Miconazole in Patients With Tinea Cruris","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":51,"lead_sponsor_name":"Galeno Desenvolvimento de Pesquisas Clínicas","has_results":false},{"nct_id":"NCT07312604","title":"A Pilot Study to Evaluate the Therapeutic Efficacy of Intra-Lesional Immunotherapy in Patients Aged 10-60 Years With Recalcitrant Tinea Cruris and Corporis","phase":"NA","overall_status":"RECRUITING","enrollment_count":50,"lead_sponsor_name":"Abeer Mohamed Abdelaziz Elkholy","has_results":false},{"nct_id":"NCT03676686","title":"Study With Nåva Foot Cream in Patients With Tinea Pedis Interdigitalis","phase":"NA","overall_status":"COMPLETED","enrollment_count":46,"lead_sponsor_name":"Natumin Pharma AB","has_results":false},{"nct_id":"NCT05363449","title":"Safety, Tolerability, and Pharmacokinetics of UHE-103 Cream in Subjects With Tinea Cruris and/or Tinea Pedis","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":42,"lead_sponsor_name":"Therapeutics, Inc.","has_results":false},{"nct_id":"NCT03999437","title":"SINGLE-APPLICATION TERBINAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION VERSUS A SINGLE-APPLICATION BUTENAFINE HYDROCHLORIDE (1%) TOPICAL LIQUID SOLUTION FOR THE TREATMENT OF TINEA PEDIS","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":42,"lead_sponsor_name":"United Laboratories","has_results":false},{"nct_id":"NCT04315051","title":"A Trial of Safety/Efficacy of Test Article in Patients With Interdigital T. Pedis","phase":"PHASE2","overall_status":"TERMINATED","enrollment_count":39,"lead_sponsor_name":"DermBiont, Inc.","has_results":false},{"nct_id":"NCT04937920","title":"A Trial to Evaluate the Safety and Antimicrobial Efficacy of DBI-002 Probiotic in Adults With Tinea Versicolor","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":34,"lead_sponsor_name":"DermBiont, Inc.","has_results":true},{"nct_id":"NCT02767271","title":"Maximal Use of Luliconazole Cream 1% in Pediatric Participants With Moderate to Severe Tinea Pedis or Tinea Cruris","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Bausch Health Americas, Inc.","has_results":true},{"nct_id":"NCT04110834","title":"Clinical Assessment of Itraconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Sara Botros","has_results":false},{"nct_id":"NCT04110860","title":"Clinical Assessment of Voriconazole Self Nano Emulsifying Drug Delivery System Intermediate Gel","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Sara Botros","has_results":false},{"nct_id":"NCT06980493","title":"Efficacy and Safety of Topical Amphotericin B Solution in Treatment of Resistant Tinea Capitis in Children 16 Years Old or Less we Follow up Cases Weekly up to 8 Weeks and Notice Improvement of Itching ,Scaling, and Hair Regrowth Then Fungal Culture Done to See if the Solution Working","phase":"PHASE2, PHASE3","overall_status":"ACTIVE_NOT_RECRUITING","enrollment_count":30,"lead_sponsor_name":"Sohag University","has_results":false},{"nct_id":"NCT04341402","title":"Systemic Uptake of Diclofenac Sodium in Combination With Miconazole as Antifungal Nail Gel When Applied Daily With Monitoring of Hepatic and Renal Enzymes, and Serum Levels of Diclofenac 12 Hours After Application, and at 3 and 6 Months Study","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":30,"lead_sponsor_name":"William N Handelman","has_results":false},{"nct_id":"NCT03823040","title":"Clinical Assessment of Oxiconazole Nitrate Solid Lipid Nanoparticles Loaded Gel","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":28,"lead_sponsor_name":"Minia University","has_results":false},{"nct_id":"NCT04265521","title":"Study With BioCool Footcare in Subjects With Tinea Pedis Interdigitalis and Heel Cracks, Calluses and/or Dry Feet","phase":"NA","overall_status":"COMPLETED","enrollment_count":25,"lead_sponsor_name":"Biocool AB","has_results":false},{"nct_id":"NCT05493488","title":"A Trial to Evaluate the Safety and Efficacy of DBI-001 Gel, DBI-002 Gel, and Aqueous Gel in Subjects With Tinea Pedis","phase":"PHASE2","overall_status":"UNKNOWN","enrollment_count":24,"lead_sponsor_name":"DermBiont, Inc.","has_results":false},{"nct_id":"NCT02871011","title":"Nitric Oxide Releasing Solution (NORS) Footbath to Treat Athlete's Foot","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Nitric Solutions Inc.","has_results":true},{"nct_id":"NCT05730244","title":"A Study of the Clinical Efficacy and Safety of 20% Cassia Alata Extract Against Tinea Versicolor","phase":"PHASE1","overall_status":"RECRUITING","enrollment_count":20,"lead_sponsor_name":"The University of The West Indies","has_results":false},{"nct_id":"NCT02394340","title":"Study Evaluating the Drug Interaction Potential of Luliconazole Cream 1% in Participants With Tinea Pedis and Tinea Cruris","phase":"PHASE4","overall_status":"COMPLETED","enrollment_count":20,"lead_sponsor_name":"Bausch & Lomb Incorporated","has_results":true},{"nct_id":"NCT07428954","title":"Using Artificial Intelligence to Help Doctors Identify Different Skin Conditions and Improve Patient Care","phase":"","overall_status":"COMPLETED","enrollment_count":16,"lead_sponsor_name":"AI Labs Group S.L","has_results":false},{"nct_id":"NCT07428915","title":"Evaluating Legit.Health Plus Support for Improving Diagnosis of Generalized Pustular Psoriasis and Other Skin Conditions Among Primary Care Physicians and Dermatologists","phase":"","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"AI Labs Group S.L","has_results":false},{"nct_id":"NCT05202366","title":"An Open-label Study Evaluating the Effectiveness of CGB-400 Topical Gel for Fungal Infection","phase":"","overall_status":"COMPLETED","enrollment_count":15,"lead_sponsor_name":"CAGE Bio Inc.","has_results":false},{"nct_id":"NCT04152226","title":"A Trial to Evaluate the Safety and and Tolerability of DBI-001 in Patients With Tinea Pedis","phase":"PHASE2","overall_status":"COMPLETED","enrollment_count":12,"lead_sponsor_name":"DermBiont, Inc.","has_results":true}],"total":45},"guidelines":[],"source":"Drug Landscape verified database"}